Definitive Contract 75F40121C00048

Award Date 7/16/21
Potential Completion Date 9/30/25
Potential Value $3.8M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Newport News, VA 23607, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $982,640 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Resolution Think LLC, an SBA-certified Economically Disadvantaged Women-Owned Small Business, 8(a) Program Participant, and Women-Owned Small Business. The contract is for the FDA's Center for Drug Evaluation and Research (CDER) Small Business and Industry Assistance (CDER SBIA) Webinar Series. This effort supports Executive Order 14222, which implements the President's Department of...
This is a $350,038.00 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Concerted Solutions Inc., a minority-owned, self-certified small disadvantaged business. The contract is for the provision of 2016 and 2017 CDER (Center for Drug Evaluation and Research) Small Business and Industry Annual Regulatory Meetings, which are held in Washington, DC. The contract was awarded on February 11, 2016 and has an ultimate completion date of November 30, 2017. The award is...
This is a firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Concerted Solutions Inc., a minority-owned, woman-owned small business. The contract, valued at $527,266.00, is for the CDER SBIA WEBINAR SERIES, which appears to be a program within the FDA's Center for Drug Evaluation and Research (CDER). The contract was awarded on a sole-source basis under the 8(a) program, which is a set-aside for small disadvantaged businesses. The contract has an ultimate...
The U.S. Food and Drug Administration (FDA) has awarded a firm fixed-price Blanket Purchase Agreement (BPA) call order to Event Source Professionals Inc., a woman-owned small business, to provide conference support services for the International Medical Device Regulators Forum (IMDRF) 2024 event in Takoma Park, MD. The $1,272,414.67 contract will cover the company's experienced conference support specialists in areas such as venue selection, catering, audio/visual equipment, and overall event...
This is a $121,488.70 firm fixed price contract awarded by the Department of Health and Human Services Food and Drug Administration to Sidem LLC, a small disadvantaged woman-owned business, to provide public outreach meeting services for the FDA's efforts to modernize its food standards program and implement its new era of smarter food safety. The contract was awarded on an 8(a) sole source basis and is for services to be performed in Washington, DC through November 17, 2019. Sidem has...
This is a federal contract award from the Food and Drug Administration (FDA) to Event Source Professionals Inc., a woman-owned small business. The contract, valued at $238,829.50, is a Blanket Purchase Agreement (BPA) call under the General Services Administration's Multiple Award Schedule (MAS) program. The contract provides event planning support services, including venue selection, catering, audio/visual support, transportation coordination, and overall event logistics for both in-person...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Attendee Interactive LLC, a small business. The contract has a ceiling value of $734,344.20 and an ultimate completion date of December 31, 2021. The contract is for CDER CECAT software, which is likely related to the Center for Drug Evaluation and Research (CDER) and its Computer Evaluation and Consulting Assistance Team (CECAT). As this is a small business set-aside...
<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Concerted Solutions Inc., an 8(a) certified small disadvantaged business, for SBIA 2015 and 2016 hybrid meetings. The contract has a ceiling value of $247,456.00 and a completion date of December 30, 2016. The contract does not appear to be associated with a larger vehicle.</p>
This is a firm fixed price contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Fedscale Inc., an SBA certified 8(a), HUBZone, and Women-Owned Small Business (WOSB). The contract is for the provision of a Contract Management Solution, including alternatives analysis and prototyping for an Information Technology Infrastructure Library (ITIL) replacement system for the FDA Office of Information and Management Technology. The contract has a potential...
<p>This is a $607,211.51 firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Smart Consulting Group LLC, a woman-owned small business. The contract is for the development of strategies in handling high profile consent decrees, with a performance period through July 1, 2025. The contract was awarded on September 30, 2021 and is under the Multiple Award Schedule (MAS) contract vehicle. There was no set-aside used for this award.</p>

This is a $3,841,189.63 Firm Fixed Price definitive contract awarded by the Food and Drug Administration (FDA) to Resolution Think LLC, an 8(a) Certified Economically Disadvantaged Women-Owned Small Business. The contract is for the planning, delivery, and post-event activities for the FDA's CDER Small Business and Industry Assistance (CDER SBIA) conferences and events, with a period of performance through September 30, 2025. This contract was awarded as a sole source 8(a) set-aside. Resolution Think has experience delivering professional development conferences, symposiums, and webinars for government agencies, including previous FDA contracts for small business outreach related to the drug approval process.

Generated 4/5/25, 9:48 AM